ISRG vs. EW, SYK, SNY, ELV, PFE, AMGN, MDT, BSX, REGN, and VRTX
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Stryker (SYK), Sanofi (SNY), Elevance Health (ELV), Pfizer (PFE), Amgen (AMGN), Medtronic (MDT), Boston Scientific (BSX), Regeneron Pharmaceuticals (REGN), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "medical" sector.
Intuitive Surgical (NASDAQ:ISRG) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
Intuitive Surgical has a net margin of 27.16% compared to Edwards Lifesciences' net margin of 23.01%. Edwards Lifesciences' return on equity of 22.86% beat Intuitive Surgical's return on equity.
Intuitive Surgical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.
83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.8% of Intuitive Surgical shares are owned by company insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Edwards Lifesciences had 3 more articles in the media than Intuitive Surgical. MarketBeat recorded 23 mentions for Edwards Lifesciences and 20 mentions for Intuitive Surgical. Edwards Lifesciences' average media sentiment score of 0.99 beat Intuitive Surgical's score of 0.86 indicating that Edwards Lifesciences is being referred to more favorably in the news media.
Intuitive Surgical presently has a consensus target price of $396.17, suggesting a potential upside of 2.57%. Edwards Lifesciences has a consensus target price of $93.27, suggesting a potential upside of 6.40%. Given Edwards Lifesciences' higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Intuitive Surgical.
Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Edwards Lifesciences received 294 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 71.80% of users gave Edwards Lifesciences an outperform vote while only 69.05% of users gave Intuitive Surgical an outperform vote.
Summary
Intuitive Surgical beats Edwards Lifesciences on 10 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
